Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity

[1]  Michael Ruogu Zhang,et al.  Improved serodiagnosis of hepatitis C virus infection with synthetic peptide antigen from capsid protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[2]  E. Muchmore,et al.  Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune process , 1990, The Lancet.

[3]  E. Schrumpf,et al.  Measles and rubella antibodies in patients with chronic liver disease. , 1990, Journal of hepatology.

[4]  M. Houghton,et al.  HCV testing in low-risk population , 1990, The Lancet.

[5]  F. Alvarez,et al.  Autoimmune hepatitis in children and hepatitis C virus testing , 1990, The Lancet.

[6]  U. Treichel,et al.  Autoantibodies to human asialoglycoprotein receptor in autoimmune‐type chronic hepatitis , 1990, Hepatology.

[7]  D. Vergani,et al.  Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result? , 1990, The Lancet.

[8]  G. Idéo,et al.  Intrafamilial transmission of hepatitis C virus , 1990, The Lancet.

[9]  M. Lenzi,et al.  Type 2 autoimmune hepatitis and hepatitis C virus infection , 1990, The Lancet.

[10]  S. Banks,et al.  Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. , 1989, The New England journal of medicine.

[11]  S. Sherlock.  CLASSIFYING CHRONIC HEPATITIS , 1989, The Lancet.

[12]  T. Ferraro,et al.  HAZARDS OF INTERFERON THERAPY FOR HBV-SERONEGATIVE CHRONIC HEPATITIS , 1989, The Lancet.

[13]  M. Buti,et al.  HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAIN , 1989, The Lancet.

[14]  F. Alvarez,et al.  Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: A second type of “autoimmune” hepatitis , 1987, Hepatology.

[15]  R. Williams,et al.  A radioimmunoassay for detection of circulating antibodies reacting with the hepatic asialoglycoprotein receptor protein. , 1985, Journal of immunological methods.

[16]  F. Negro,et al.  Microsomal autoantibodies in chronic infection with the HBsAg associated delta (delta) agent. , 1983, Clinical and experimental immunology.

[17]  M. Losowsky,et al.  ENHANCED ANTIBODY RESPONSES IN ACTIVE CHRONIC HEPATITIS , 1976, The Lancet.

[18]  G. Leandro,et al.  One Year of Therapy of nonA, nonB/C chronic hepatitis with recombinant α-2a interferon (r-IFN) or lymphoblastoid α interferon (λ-IFN) , 1990 .

[19]  M. Loriot,et al.  Lack of mother to infant transmision of the hepatitis C virus (HCV) , 1990 .

[20]  E. Schiff,et al.  Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. , 1989, The New England journal of medicine.

[21]  F. Chiodo,et al.  Liver autoreactivity in acute virus A, B and non-A, non-B hepatitis. , 1988, Journal of clinical & laboratory immunology.

[22]  D. Vergani,et al.  Serum autoantibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disorders. , 1986, Journal of hepatology.

[23]  I. Mackay,et al.  Absence of autoimmune serological reactions in chronic non A, non B viral hepatitis. , 1985, Clinical and experimental immunology.